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Trends in the in-hospital stroke rate following
carotid endarterectomy in California and Maryland
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Glen S. Roseborough, MD,c and G. Melville Williams, MD,c Baltimore, Md
Objective:We examined the outcome of carotid endarterectomy (CEA) in the state of Maryland during the last decade to
identify any trends in the incidence of in-hospital stroke and mortality and compared these results with the outcome of
the operation throughout the state of California as a control population.
Method: We performed a retrospective analysis of 10 years (1994 to 2003) of the Maryland and 5 years (1999 to 2003)
of the California hospital discharge databases. The following patients were included in the analysis: (1) International
Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) procedure code 38.12 (endarterectomy of the
vessels of the head and neck other than intracranial vessels) in the primary coding position but not in any secondary
position, or (2) the diagnosis code 433.00 to 433.91 (occlusion/stenosis, precerebral artery), or (3) the diagnosis-related
group (DRG) 5 (extracranial vascular procedure). Symptomatic patients were identified by history of previous stroke
(ICD-9 codes 342 or 438), transient ischemic attack (435 or 781.4), or amaurosis fugax (362.34 or 368.12). In-hospital
strokes were identified by ICD-9 codes 997.0, 997.00, 997.01, and 997.09. Low-, moderate-, and high-volume surgeons
were defined as performing <15, 15 to 74 and >75 CEAs annually. Hospital volumes were similarly classified as low for
those performing <20 CEAs, moderate for 21 to 100, and high for >100 annually.
Results: In the Maryland data, 23,237 CEA cases were identified with 169 in-hospital strokes over 10 years (0.73%),
whereas the 51,331 California CEAs had 232 in-hospital strokes over 5 years (0.45%). The stroke rate in Maryland was
2.12% in 1994, 1.47% in 1995, and 0.29% to 0.65% from 1996 to 2003. The decrease in strokes was more pronounced
among symptomatic patients, where the rate was 3.82% in 1994, 4.44% in 1995, and 0.90% to 2.29% from 1996 to 2003.
A similar decrease was identified in the asymptomatic patient population but was less pronounced: 1.64% in 1994, 0.81%
in 1995, and 0.15% to 0.44% from 1996 to 2003. The low recent stroke rates were confirmed by the California data
(0.44% to 0.48% from 1999 to 2003). Changes in the death rate for CEA during this time frame have not been as
pronounced, from 0.33% to 0.58% for Maryland and 0.78% to 0.91% for California.
Conclusions: A dramatic decrease in the in-hospital stroke rates in Maryland occurred around 1995. The stroke rates in
Maryland in the past 5 years are similar to those in California during the same period. An analysis of data from the two
states shows that the in-hospital stroke rate now for carotid endarterectomy is approximately 0.54%. (J Vasc Surg 2006;
44:488-95.)
In the last five decades, carotid endarterectomy (CEA)
has emerged as the gold standard treatment for carotid
artery disease.1-3 The safety and efficacy of this procedure
and its superiority compared with the best medical manage-
ment of patients with symptomatic and asymptomatic ca-
rotid stenoses, respectively, was clearly demonstrated by the
North American Symptomatic Carotid Endarterectomy
Trial (NASCET) and Asymptomatic Carotid Atherosclero-
sis Study (ACAS).4-5 Percutaneous carotid angioplasty and
stenting has emerged more recently as an alternative treat-
ment for carotid artery disease. The ultimate role of this
endovascular approach to carotid disease will depend on its
overall risk compared with the risk of traditional endarter-
ectomy.
Because NASCET and ACAS were conducted in ter-
tiary referral centers in which the operations were per-
formed by highly vetted surgeons, some have questioned
whether these results truly reflect the risk of the procedure
as performed in the surgical community at large. Further-
more, much of the published literature with respect to the
outcome of CEA is also reported from large academic
medical centers.6-8 In light of that, we previously reported
a population-based analysis of the outcome of nearly
10,000 consecutive CEAs performed in 48 hospitals in the
state of Maryland from 1992 through 1996 and docu-
mented a statewide in-hospital stroke/mortality rate of
2.6%.9
The present study examined the outcome of CEA in
the state of Maryland during the last decade to identify any
trends in the incidence of in-hospital stroke and mortality
and to compare these results with the outcome of the
operation throughout the state of California as a control
population.
METHODS
The Maryland Health Services Cost Review Commis-
sion (HSCRC) database was retrospectively analyzed for
the last 10 years (1994 to 2003) for which data are
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available. A similar analysis was performed on the California
Office of Statewide Health Planning and Development
(OSHPD) database for the most recently available 5 years
(1999 to 2003). Appropriate cases were identified by a
previously reported algorithm.9-10 In brief, this included
(1) International Classification of Diseases, 9th Revision,
Clinical Modification (ICD-9-CM) procedure code 38.12
(endarterectomy of the vessels of the head and neck other
than intracranial vessels) in the primary coding position but
not in any secondary position, or (2) diagnosis code 433.00
to 433.91 (occlusion/stenosis, precerebral artery), or (3)
the diagnosis-related group (DRG) 5 (extracranial vascular
procedure). The accuracy of this algorithm was confirmed
by a chart review at the Johns Hopkins Hospital (Fig 1).
In-hospital strokes were identified by ICD-9 codes
997.0, 997.00, 997.01, and 997.09 (Fig 2). Symptomatic
patients were identified by history of previous stroke
(ICD-9 codes 342 or 438), transient ischemic attack (435
or 781.4), or amaurosis fugax (362.34 or 368.12) (Fig 3).
These ICD-9 codes were derived from the hospital coders,
who are charged with reviewing every chart. Sides of strokes
and side of carotid endarterectomy were not obtainable
from the databases. We examined all ICD-9 codes in the
database; we did not limit our investigation to Charlson
diagnosis codes. Low-, moderate-, and high-volume sur-
geons were defined as performing 15, 15 to 74 and 75
CEAs annually.11 Hospital volumes were similarly classified
as low for those performing20 CEAs, moderate for 21 to
100, and high for 100 annually.12 We used Stata SE 9.0
(Stata Corp, College Station, TX) for data analysis.
RESULTS
From 1994 to 2003, CEA was performed on 23,237
patients in Maryland in 47 hospitals by 438 surgeons, with
an overall stroke rate of 0.73%; however, 465 patients were
missing surgeon identifiers. There were 54.7% men and
45.3% women aged from 33 to 99 years (mean, 70.6 years).
There were 21,229 white (91.4%) and 1,682 black (7.2%)
patients. The indication for operation was symptomatic
disease in 15.2% patients, who experienced a higher CEA
stroke rate of 2.16%. In contrast, the stroke rate for asymp-
tomatic patients was 0.47%. The percentage of asymptom-
atic patients increased during the study period, from 78.1%
in 1994 to 87.9% in 2004.
The average age of the 169 patients who had postop-
erative strokes was 70.7 years vs 70.6 years for patients
without strokes (P  NS). The population of stroke pa-
tients comprised 52.7% men vs 54.7% without strokes
(P  NS). Significantly more of the patients who had
strokes were black: 16.1% vs 7.3% of the population with-
out strokes (P  .001).
High-, moderate- and low-volume Maryland surgeons
performed 2134 CEAs (9.2%), 15,674 (67.5%) and 5429
(23.4%), respectively. For all patients, low-volume sur-
geons saw higher rates of stroke (1.01%) compared with
moderate (0.68%) or high-volume surgeons (0.37%) (P 
.006). When stratified by symptomatic vs asymptomatic
status, however, this association only persisted for asymp-
Fig 1. Identification of carotid endarterectomy (CEA).
Fig 2. Identification of in-hospital stroke. CEA, Carotid endar-
terectomy; ICD-9, International Classification of Diseases, 9th
Revision; CNS, central nervous system; *, subgroup of ICD-9
coding system.
Fig 3. Identification of symptomatic patients. ICD-9, Interna-
tional Classification of Diseases, 9th Revision; *, subgroup of
ICD-9 coding system.
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tomatic patients (P .006). Of note, on logistic regression,
this apparent association between surgeon volume and
stroke rate disappeared when controlled for black vs white
race.
From 1999 to 2003, CEA was performed on 51,331
patients in the state of California, with an overall stroke rate
of 0.45% (232 patients). This patient population comprised
57.0% men aged from 25 to 85 years (mean, 73.5 years).
There were 74.1% white patients and 20.4% black patients.
The 14.7% symptomatic patients had a stroke rate of 0.41%;
the asymptomatic patients had a stroke rate of 0.46%.
During the 10-year study period, low-volume hospi-
tals in Maryland accounted for 1147 (4.94%), moderate-
volume hospitals 12,040 (51.81%), and high-volume
hospitals 10,050 (43.25%) CEAs. The stroke rate in low-
volume hospitals in Maryland was 1.39%, those with mod-
erate volume had 0.77%, and high-volume hospitals had
0.60% (P  .008). Similarly as with surgeon volumes, this
association remained significant only for asymptomatic pa-
tients (P  .030).
On logistic regressionof theMarylanddata, black vswhite
race, calendar year, and symptoms were significantly associ-
ated with stroke (all P  .001). Hospital volume, surgeon
volume, age, and gender were nonsignificant. However, on
logistic regression for death in Maryland patients, only
symptoms emerged as significant, with an odds ratio of
2.12 for death (P  .001). Age and surgeon volume had
equivocal odds ratios of 1.05 and 0.99 respectively, al-
though P  .05.
On analysis over the study period, the stroke rates in
both Maryland and California decreased over time (Fig 4).
The stroke rate was 2.12% in 1994, 1.47% in 1995, and
0.29% to 0.65% from 1996 to 2003. The decrease in stroke
incidence was more pronounced among symptomatic pa-
tients in Maryland, where the rate was 3.82% in 1994,
4.44% in 1995, and then 0.90% to 2.29% from 1996 to
2003. A similar decrease was identified in the asymptomatic
patient population but was less pronounced: 1.64% in
1994, 0.81% in 1995, and 0.15% to 0.44% from 1996 to
2003 (Fig 5). The most sizeable annual decrease occurred
between 1995 (overall stroke rate, 1.47%) and 1996
(0.53%). In California, the overall stroke rate was 0.60% in
1999, remaining steady at 0.53% in 2003.
The Maryland CEA mortality was 0.54% from 1994 to
2003, with a comparable rate of 0.48% in California for
1999 to 2003. There was little variability in the in-hospital
mortality rates, ranging from 0.33% to 0.58% over the
decade in Maryland and from 0.78% to 0.91% during the
5-year interval in California (Fig 6).
DISCUSSION
After its introduction into clinical practice in the 1950s,
the volume of CEAs performed in this country grew pro-
gressively during the next three decades. Scattered reports
citing excessively high rates of perioperative stroke and
death raised significant concerns about the safety and utility
of this procedure, however. For example, in a community-
based report from Illinois, Easton and Sherman13 docu-
mented a perioperative stroke rate of 14.5% and mortality
of 6.6% after CEA. In a highly publicized report, the
RAND Corporation identified a perioperative stroke and
death rate of 9.8% among Medicare beneficiaries.14
Fig 4. Carotid endarterectomy stroke rate trends in Maryland
and California.
Fig 5. Carotid endarterectomy stroke rate trends in Maryland for
symptomatic vs asymptomatic patients.
Fig 6. Carotid endarterectomy death rate trends inMaryland and
California.
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These experiences resulted in a marked reduction in the
performance of CEA for several years. In fact, it was not
until the mid-1990s that the NASCET and ACAS investi-
gations clearly established the safety and efficacy of CEA.4-5
Although the number of CEAs performed in this country
has substantially grown since that time, some still believe
that the outcomes documented in NASCET and ACAS,
and in reports from individual centers of excellence, may
not reflect the true outcome of the procedure in the surgical
community at large. It was within that context that we
studied the outcome of CEA throughout the state of
Maryland in the mid-1990s.
We documented an in-hospital stroke rate of 1.7% and
a death rate of 0.9% among a series of 9918 CEAs per-
formed in 48 hospitals by 200 surgeons.9 The current
study clearly demonstrates that the outcomes of CEA have
continued to improve since that earlier investigation. Fur-
thermore, using the California database as a control or
comparison population, we identified a similar excellent
outcome of the procedure in a state geographically remote
from Maryland.
The treatment of carotid artery disease is clearly in
evolution with the introduction and growth of carotid
angioplasty and stenting, and its ultimate place in our
therapeutic armamentarium will depend upon its docu-
mented risks compared with CEA. At present, carotid
stenting appears most appropriate for management of pa-
tients deemed to be at high risk for CEA. A study of
528 patients undergoing carotid stenting found a 30-day
stroke/death rate of 7.4%.15 In the industry-supported
Stenting and Angioplasty with Protection in Patients at
High Risk for Endarterectomy (SAPPHIRE) trial, 334
high-risk patients were randomized to carotid stenting vs
CEA. The 30-day stroke and death rates were 6.2% and
7.9% for stenting and CEA, respectively.16-17 However, the
initial Food and Drug Administration approval of carotid
stenting was based upon results collected in the Acculink
for Revascularization of Carotids in High-Risk Patients
(ARCHeR) carotid stent registry. Among the three trials
included in this investigation, the 30-day stroke rate was
4.4% to 6.2%, and the 30-day stroke and death rates were
6.9% to 8.0%.18
Although these investigations indicate that carotid
stenting may be performed with reasonable safety, numer-
ous reports document excellent results of CEA when per-
formed on so-called high-risk patients. For example, in a
series of 1198 patients undergoing CEA, Reed et al19
reported a perioperative stroke incidence of 2.3% among
high-risk vs 1.0% among low-risk patients.19 This experi-
ence has been mirrored in other institutions. In a study of
778 patients undergoing CEA, 323 high-risk patients de-
fined as SAPPHIRE-eligible experienced a perioperative
stroke and death rate of 2.5% vs 1.1% in low-risk patients.20
In another study of 803 patients undergoing CEA at the
University of Rochester, high-risk patients were defined as
ARCHeR-eligible. The perioperative stroke and death rates
were 3.1% among the 128 high-risk and 2.1% among 675
low-risk patients.21 Lepore et al22 reported a perioperative
stroke and death rate of 1.5% among patients who would
have been ineligible for NASCET and ACAS vs 3.5%
among trial-eligible patients. It is noteworthy that 46% of
the patients in this experience were “trial ineligible” or high
risk. These studies clearly indicate that so-called high-risk
patients routinely undergoCEA in tertiary care centers, and
with excellent outcomes.22
The methodology of the present study does not allow
the identification of “high-risk” CEA patients, but it clearly
demonstrates that excellent results are being achieved in
contemporary practice across a broad spectrum of surgical
practices and not just in tertiary care centers. The salutary
Maryland results are not unique. We have demonstrated
comparable outcomes using the California database. In a
previous study intended to improve surgical outcomes,
including 14 states and 40,771 CEAs, the stroke rate was
2.0% to 2.5% in 1996.23 Furthermore, in a national study of
35,821 patients undergoing CEA by 2330 surgeons in 372
hospitals as documented in the National Inpatient Sample,
the in-hospital stroke rate was 1.45% (Chang DC et al,
unpublished data).
The reasons for this improvement in outcomes com-
pared with our previous report from Maryland in the mid-
1990s may be multifactorial. It has been suggested that
more compulsive attention to intraoperative cerebral pro-
tection and the use of selective shunting through intraop-
erative electroencephalographic monitoring, measurement
of carotid stump pressure, and the use of awake regional
cervical block anesthesia and other modalities may be con-
tributing to improved outcomes.24 Another study from our
group25 documented an association between calendar year
and patient outcome; specifically, every increment in calen-
dar year was associated with an odds ratio of death of 0.935
(P  .04).25
Another striking observation in the present study was
the changing pattern in terms of indications for operation.
Specifically, 85% of the CEAs in this study were performed
for asymptomatic carotid artery disease, and the proportion
of CEAs performed for asymptomatic disease increased
from 78.1% in 1994 to 87.9% in 2003. There is no question
that the risk of perioperative complications is lowest among
patients who undergo operation for asymptomatic carotid
stenoses,10,26 and this may be a very critical factor respon-
sible for the outstanding results documented in this study.
We clearly demonstrated an increased rate of perioperative
complications among patients who underwent CEA for
symptomatic carotid disease.
Unfortunately, it is beyond the methodology of this
study to characterize more objectively the asymptomatic
patients in terms of the degree of stenosis, the extent of
contralateral carotid disease, and other factors thatmight have
influenced the selection of these patients for operation. Nev-
ertheless, there is convincing evidence to supportCEA among
patients with asymptomatic carotid disease if the procedure
can be performed with a very low rate of perioperative com-
plications. For example, in a Cochrane27 analysis of three
trials including 5223 patients, the “operation-related” peri-
operative stroke and death rate was 2.9%. It was concluded
JOURNAL OF VASCULAR SURGERY
Volume 44, Number 3 Matsen et al 491
that for the primary outcome of perioperative stroke and
death, patients undergoing CEA fared better than those
treated medically, with a relative risk (RR) 0.69 and 95%
confidence interval (CI) of 0.57 to 0.84. For the outcome
of “any stroke or death” there was a nonsignificant trend
towards fewer events in the surgical group (RR, 0.92; 95%
CI, 0.83 to 1.02). The authors concluded that despite
about a 3% perioperative stroke or death rate, CEA for
asymptomatic carotid stenosis reduces the risk of ipsilateral
stroke and any stroke by approximately 30% over 3 years.27
Consistent with previous reports,28 we did document
an increased rate of in-hospital stroke among lower-volume
carotid surgeons. Using our forthcoming evidence-based
volume tiers for carotid surgeons, we found a highly signif-
icant difference (P  0.006) in stroke rate amongst those
surgeons performing 15 CEAs annually (stroke rate,
1.01%) compared with those performing a moderate yearly
volume (15 to 74, 0.68%) and a high volume (74,
0.37%). Surgeon volume, however, did not carry over as a
significant factor in outcome on logistic regression except
for asymptomatic patients. It is not clear why the signifi-
cance of this relationship was unique to asymptomatic
patients. It may be that asymptomatic patients undergoing
CEA are at a higher risk for stroke in unexperienced hands
than previously recognized. It could be that surgeons are
more cavalier when operating on asymptomatic patients,
perhaps cutting short some of the safety precautions they
embrace for patients with symptomatic lesions.
The reasons for the greater proportion of black patients
with in-hospital strokes (16.1% vs 7.3% of the population
without strokes, P  0.001) are unclear. On the contrary,
we did not find a race effect for in-hospital death after CEA.
It may be that black patients present to surgeons and
hospitals with less experience. In fact, the surgeon volume
effect disappeared for the outcome of stroke when con-
trolled for black vs white race. We did not control for
comorbidities in our study, but black patients may have
greater comorbidities leading to a higher rate of adverse
outcomes. Alternately, genetic factors that are heretofore
uncharacterized may affect carotid disease.
Of interest, black patients were not identified as having
higher rates of symptomatic disease. Although they were
7.2% of the study population, they comprised only 6.7% of
the symptomatic patients. White patients, in contrast, com-
prised 91.4% of the study population, but counted towards
92.0% of the symptomatic patients. Of course, the possibil-
ity remains that black patients were not correctly triaged as
having symptoms, and that this would indeed be a factor in
their worse outcomes.
Some potential limitations of this study warrant discus-
sion. In light of the remarkably low rate of perioperative
complications documented in this analysis, even when
compared with our previous study in Maryland, the possi-
bility of under-reporting of complications in the database
must be considered. Indeed, this is a potential problem in
the analysis of all administrative databases. We addressed
this potential limitation as comprehensively as possible.
First, we interrogated the California database and
found a comparable outcome of CEA. More important, we
verified the data in theMarylandHSCRC database with the
results of CEA at Johns Hopkins Hospital as recorded in
our internal database, and we could uncover no errors in
coding. Furthermore, in an era when hospital reimburse-
ment is intimately dependent upon accurate coding, we
believe it is unlikely that a significant number of perioper-
ative strokes would have been missed. Certainly, one could
argue that the extent of under-reporting should be rela-
tively constant over time. In that regard, since our meth-
odology is the same as that used in our previous report from
Maryland, the current report clearly documents a remark-
able improvement in outcome over time compared with
that previous report.
Because the length of stay after CEA has progressively
declined over time, it is possible that some perioperative
adverse events may have occurred after hospital discharge.
However, because almost all perioperative strokes occur
intraoperatively or in the first few hours postoperatively, we
think it is very unlikely that this is a relevant explanation for
the excellent results in this study.29 Furthermore, it is
exceedingly unlikely that a perioperative death would be
missed in the coding process, and we have also documented
a progressive decrease in the rate of perioperative mortality
when compared to our previous study.
It is also possible that imprecise coding was partly
responsible for the very high rate of operations performed
for asymptomatic carotid disease during this interval.
Again, we validated the database in terms of operative
indications against our internal Johns Hopkins database
and identified no coding errors in this regard. We also used
the same coding algorithm to identify symptomatic patients
in this study as in our previous work, and the incidence of
operations performed for asymptomatic carotid stenoses
clearly increased. Rather, we believe it is much more plau-
sible that the excellent outcomes we documented reflect
the high rate of asymptomatic cases in this series. The
present study contains a higher rate of asymptomatic pa-
tients (roughly 85% in both states) than most reported
studies.17,20,30-31
CONCLUSION
This study confirms that CEA has become a very safe
procedure in contemporary practice. Among 23,237 pa-
tients undergoing CEA from 1994 to 2003, the in-hospital
stroke rate was 0.73% and the stroke and death rate was
1.3%. A dramatic decrease in the in-hospital stroke rates in
Maryland occurred around 1995. The stroke rates seen
in Maryland over the past 5 years are similar to those seen
in California during the same period. Although carotid
angioplasty and stenting continue to improve, it seems
undeniable that the outcome of CEA is also improving.
Therefore, the outcomes of carotid stenting must be com-
pared to the most recent outcomes of CEA and not to
historical reports.
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DISCUSSION
Dr Thomas Huber (Gainesville, Fla). The authors have ana-
lyzed the outcome after carotid endarterectomy in both Maryland
and California over several years using administrative databases.
They reported that the overall stroke and mortality rates were less
than 1% in both states. The stroke rate decreased over the 10-year
time period of the study in Maryland, with race, calendar year, and
symptomatology associated with an increased incidence of stroke
by logistic regression. Not surprising, the stroke rates in Maryland
were inversely related to both hospital and provider specific vol-
umes. I have three questions/requests for the authors.
First, the utility of carotid endarterectomy represents a balance
between the risk of stroke associated with the procedure itself and
medical management. Although I would like to believe that stroke
risk associated with carotid endarterectomy is less than 1% in the
two states analyzed, I suspect that the actual rate is significantly
higher and that the incidence of stroke is under-reported in the
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